Adamas Pharmaceuticals, Inc. EBITDA Margin 2014-2021 | ADMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Adamas Pharmaceuticals, Inc. (ADMS) over the last 10 years. The current EBITDA margin for Adamas Pharmaceuticals, Inc. as of September 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-09-30 | $0.09B | $-0.04B | -43.18% |
| 2021-06-30 | $0.08B | $-0.04B | -51.22% |
| 2021-03-31 | $0.08B | $-0.04B | -50.63% |
| 2020-12-31 | $0.07B | $-0.04B | -59.46% |
| 2020-09-30 | $0.07B | $-0.05B | -72.46% |
| 2020-06-30 | $0.06B | $-0.07B | -103.17% |
| 2020-03-31 | $0.06B | $-0.08B | -138.60% |
| 2019-12-31 | $0.06B | $-0.09B | -167.27% |
| 2019-09-30 | $0.05B | $-0.10B | -184.62% |
| 2019-06-30 | $0.05B | $-0.10B | -206.12% |
| 2019-03-31 | $0.04B | $-0.11B | -250.00% |
| 2018-12-31 | $0.04B | $-0.12B | -328.57% |
| 2018-09-30 | $0.02B | $-0.12B | -513.04% |
| 2018-06-30 | $0.01B | $-0.11B | -925.00% |
| 2018-03-31 | $0.00B | $-0.10B | -2525.00% |
| 2017-09-30 | $0.00B | $-0.07B | inf% |
| 2017-06-30 | $0.00B | $-0.07B | inf% |
| 2016-12-31 | $0.00B | $-0.06B | inf% |
| 2016-09-30 | $0.00B | $-0.06B | -6200.00% |
| 2016-06-30 | $0.00B | $-0.06B | -3100.00% |
| 2016-03-31 | $0.00B | $-0.06B | -2950.00% |
| 2015-12-31 | $0.00B | $-0.06B | -2850.00% |
| 2015-09-30 | $0.03B | $-0.03B | -80.65% |
| 2015-06-30 | $0.03B | $-0.02B | -66.67% |
| 2015-03-31 | $0.06B | $0.01B | 20.00% |
| 2014-12-31 | $0.06B | $0.02B | 30.91% |
| 2014-09-30 | $0.07B | $0.04B | 55.38% |
| 2014-06-30 | $0.07B | $0.04B | 66.15% |
| 2014-03-31 | $0.04B | $0.02B | 57.50% |
| 2013-12-31 | $0.07B | $0.06B | 78.87% |
